Skip to main content

Tweets

ACR24 RA Topic Panel: Innovations in Rheumatoid Arthritis https://t.co/dHiRacDmWc

Dr. John Cush @RheumNow ( View Tweet )

3 months 1 week ago
ACR24 PsA Topic Panel Advancing Care for Psoriatic Arthritis Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for… https://t.co/j0063RpVCi https://t.co/LCINZvUR5s
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
Standardizing Still’s Disease Research: Global Data Harmonization Needed A recent study presented at #ACR24 convergence highlights significant gaps and inconsistencies in the research of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD).… https://t.co/ugsfRj2fnS https://t.co/UJmNvAMo1c
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
ACR24 SpA Panel: Key Discussions on Spondyloarthritis Join panelists Dr. Sheila Reyes, Dr. Adela Castro, Dr. Lihi Eder and Dr. Marina Magrey as they discuss key highlights and takeaways on spondyloarthritis sessions and abstracts presented at the 2024 ACR meeting in Washington,… https://t.co/XGcR6WDBFO https://t.co/0mJ08nheJJ
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
Study of 16,598 CAD pts showed in pts w/ normal hsCRP<2mg/L, increasing SUA didnt predict CV/MACE events. But if the hsCRP≥2 mg/L, increasing urate(SUA)was signif. assoc w/ increased MACE. Each 1mg incr in SUA yielded an 11% increase in MACE (adj p < 0.001)… https://t.co/9ehtOcoeBK https://t.co/t9IWQ8WUvY
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
Autoantibodies, found in over half of adult and paediatric patients with idiopathic inflammatory myopathies (IIMs), these correlate with clinical phenotypes, aiding in classification and prognosis. https://t.co/ZRXqtEec6s https://t.co/jkUe9bRlmU
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
Why should rheumatologists care about aging? As a herald to what was to come in Washington, the publication of the Lancet Rheumatology series on aging coming just days before #ACR24 set the stage for the “grey tsunami” of geriatric rheumatology that was to follow.… https://t.co/XfB7ykV0Xs https://t.co/51Cjz3EGyn
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
RA-ILD in the Spotlight at #ACR24 Over the past 5 years, there has been growing interest in RA-ILD due to its relative prevalence and severity. This seems to be one of the few RA outcomes not improving much, even with the advent of expanded treatment options.… https://t.co/MIPXW9EgVa https://t.co/kX0hDq8NTH
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
The Case for JAKi in PMR Dr. David Liew abstract 0858, Baricitinib in Early Polymyalgia Rheumatica (BACHELOR Study), presented at #ACR24. https://t.co/NLF75PuMOb https://t.co/FpUUdbtrwf
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
What Lies Beneath: Understanding Nailfold Capillaroscopy Capillaroscopy is a non-invasive imaging technique used for the in vivo assessment of the microcirculation. It can be performed using various optical instruments, but only the dermatoscope and videocapillaroscope have… https://t.co/JK9EvuxWEV https://t.co/77AcwfKIzE
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Dr. Mike Putman discusses abstract 0670, presented at #ACR24. https://t.co/QiWdioliDi https://t.co/DPRA58vyUn
Dr. John Cush @RheumNow ( View Tweet )
3 months 1 week ago
ANA+ and no Autoimmune Disease? Check the liver Dr. Janet Pope discusses abstract 0627, presented at #ACR24. https://t.co/4HV2kqjibL https://t.co/kmVcvUZtRQ
Dr. John Cush @RheumNow ( View Tweet )
3 months 2 weeks ago
×